ImmunityBio, Inc. shared a post on X:
“We are pleased to share that Dr. Patrick Soon-Shiong, Founder, Executive Chairman, and Global Chief Scientific and Medical Officer of ImmunityBio will participate as a featured speaker at the ‘Cancer 2035: A Roadmap for the Future’ Summit hosted by the Milken Institute
and the Richard Nixon Foundation.
The summit convenes leading experts across science, medicine, and policy to advance collaborative solutions aimed at meaningfully reducing cancer mortality by 2035. Read more:”
Pat Soon-Shiong, Chairman of Chan Soon-Shiong Family Foundation, Executive Chairman at ImmunityBio, and Executive Chairman of the Los Angeles Times, shared this post, adding:
“Looking forward to explaining and deconstruct the mind map of 2016…a decade later we are finally on this path of harnessing the power of our innate and adaptive immune system with IL-15 as the orchestrator.
Adapting to the quantum state – plasticity of both the tumor itself as it reacts to the treatment we administer and the immune system in the tumor micro environment that morphs from a killer state to an immunosuppressive state… depending on what, when we administer our current standards of care…
The need to understand this dynamic is complex yet simple… at the end ALC matters and overcoming lymphopenia is critical to winning the war… by harnessing the power within and driving towards memory T and NK cells.”
More from ImmunityBio, Inc. on OncoDaily.
